Kelly Jeffery W. 4
4 · PROTEOSTASIS THERAPEUTICS, INC. · Filed Jul 1, 2019
Insider Transaction Report
Form 4
Kelly Jeffrey W.
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-27+15,300→ 15,300 totalExercise: $0.94Exp: 2029-06-27→ Common Stock (15,300 underlying)
Footnotes (1)
- [F1]These securities shall vest and become exercisable in equal quarterly installments starting on June 27, 2019 until the option is fully vested and exercisable on June 27, 2020, subject to continued service.